Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.

Saved in:
Bibliographic Details
Title: Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.
Authors: Siegert E; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Phithak E; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Albach FN; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, c/o Charité - Universitätsmedizin Berlin, Berlin, Germany., Biesen R; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Drzeniek NM; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; BIH Center for Regenerative Therapies, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA., Dzamukova M; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany., Haase I; Division of Rheumatology and Systemic Inflammatory Diseases, III, Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Søndergaard K; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Schleser D; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany., Fiebig L; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany., Sattler A; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Minopoulou I; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Rehm MC; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Kremer P; Division of Rheumatology and Systemic Inflammatory Diseases, III, Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schneider U; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Rheumatology and Clinical Immunology, Immanuel Krankenhaus, Berlin, Germany., Trezzini S; Faculty of Medicine and Dentistry, University La Sapienza, Rome, Italy., Rein AMC; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Mayer CM; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany., Doellinger F; Department of Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany., Furth C; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany., Staeck A; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Cheng Q; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany., Sinzinger B; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany., Unterwalder N; Department of Immunology, Labor Berlin - Charité Vivantes GmbH, Berlin, Germany., Ohrndorf S; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Departement of Gastroenterology, Hepatology, Infectious Diseases and Rheumatology, Klinikum Ernst von Bergmann Potsdam, Potsdam, Germany; Institute for Clinical Research and Systems Medicine. Health and Medical University Potsdam, Potsdam, Germany., Probst M; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany., Li Y; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany., Grund D; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany., Walter-Rittel T; Department of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Fleischmann A; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany., Wiebe E; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Hütter-Krönke ML; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Keller U; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany; ImmunoPreCept Cluster, Berlin, Germany., Krönke J; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Hematology and Oncology, Universitätsmedizin Greifswald, Greifswald, Germany., Busse A; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Kleyer A; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Pecher AC; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Henes J; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Troldborg A; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Hauser AE; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany., Kötter I; Division of Rheumatology and Systemic Inflammatory Diseases, III, Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Krusche M; Division of Rheumatology and Systemic Inflammatory Diseases, III, Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Krönke G; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, c/o Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany; ImmunoPreCept Cluster, Berlin, Germany., Alexander T; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany. Electronic address: tobias.alexander@charite.de., Simon D; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, c/o Charité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Institute, Berlin, Germany.
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2026 Jun 18. Date of Electronic Publication: 2026 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1016/j.ard.2026.05.023